Tenet Healthcare (THC) Tops Q2 EPS by 41c, provides guidance

Tenet Healthcare (NYSE: THC) reported Q2 EPS of $2.31, $0.41 better than the analyst estimate of $1.90. Revenue for the quarter came in at $5.1 billion versus the consensus estimate of $4.99 billion.

GUIDANCE:

Tenet Healthcare sees Q3 2024 EPS of $2.16-$2.58, versus the consensus of $1.67. Tenet Healthcare sees Q3 2024 revenue of $5-5.1 billion, versus the consensus of $4.889 billion.

For earnings history and earnings-related data on Tenet Healthcare (THC) click here.

You May Also Be Interested In

• Gulfport Energy and Mobility Global to join S&P SmallCap 600
• GameStop 'remains focused on advancing' proposed eBay deal, offers adjusted EBITDA guidance - Filing
• Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance